Glucocorticoid regulation of the vitamin D receptor.
Many studies indicate calcitriol has potent anti-tumor activity in different types of cancers. However, high levels of vitamin D can produce hypercalcemia in some patients. Glucocorticoids are used to ameliorate hypercalcemia and to enhance calcitriol anti-tumor activity. Calcitriol in combination with the glucocorticoid dexamethasone (Dex) increased vitamin D receptor (VDR) protein levels and ligand binding in squamous cell carcinoma VII (SCC). In this study we found that both calcitriol and Dex induce VDR- and glucocorticoid receptor (GR)-mediated transcription respectively, indicating both hormone receptors are active in SCC. Pre-treatment with Dex increases VDR-mediated transcription at the human CYP24A1 promoter. Whereas, pre-treatment with other steroid hormones, including dihydrotestosterone and R1881, has no effect on VDR-mediated transcription. Real-time PCR indicates treatment with Dex increases Vdr transcripts in a time-dependent manner, suggesting Dex may directly regulate expression of Vdr. Numerous putative glucocorticoid response elements (GREs) were found in the Vdr gene. Chromatin immuno-precipitation (ChIP) assay demonstrated GR binding at several putative GREs located within the mouse Vdr gene. However, none of the putative GREs studied increase GR-mediated transcription in luciferase reporter assays. In an attempt to identify the response element responsible for Vdr transcript regulation, future studies will continue to analyze newly identified GREs more distal from the Vdr gene promoter.
Hidalgo
Alejandro A
AA
Department of Biochemistry, State University of New York at Buffalo, Buffalo, NY 14214, United States.
Trump
Donald L
DL
Johnson
Candace S
CS
D000818:Animals; D002117:Calcitriol / Q000378:metabolism; D002294:Carcinoma, Squamous Cell / Q000378:metabolism; D047369:Chromatin Immunoprecipitation; D003907:Dexamethasone / Q000378:metabolism; D005786:Gene Expression Regulation; D005938:Glucocorticoids / Q000378:metabolism*; D006801:Humans; D006934:Hypercalcemia / Q000378:metabolism; D051379:Mice; D008954:Models, Biological; D011401:Promoter Regions, Genetic; D018167:Receptors, Calcitriol / Q000378:metabolism*; D020218:Response Elements; D013250:Steroid Hydroxylases / Q000235:genetics; D065668:Vitamin D3 24-Hydroxylase
D005938:Glucocorticoids; D018167:Receptors, Calcitriol; D003907:Dexamethasone; D013250:Steroid Hydroxylases; C585549:CYP24A1 protein, human; C585550:Cyp24a1 protein, mouse; D065668:Vitamin D3 24-Hydroxylase; D002117:Calcitriol
Biochem Biophys Res Commun. 1993 Sep 30;195(3):1345-53
8216267
Cancer Res. 2009 Feb 1;69(3):967-75
19141646
Mol Endocrinol. 2002 Jun;16(6):1269-79
12040014
Clin Cancer Res. 2001 Dec;7(12):4164-73
11751517
Oncogene. 2007 Mar 22;26(13):1885-96
17016446
J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):425-9
17368182
Arch Biochem Biophys. 2000 May 15;377(2):273-83
10845704
J Endocrinol. 2000 Mar;164(3):339-48
10694374
J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):352-6
17240138
J Natl Cancer Inst. 1998 Jan 21;90(2):134-41
9450573
J Steroid Biochem Mol Biol. 2007 Mar;103(3-5):768-70
17368191
Mol Endocrinol. 2010 Jan;24(1):128-47
19897601
Biochem Biophys Res Commun. 1982 Apr 29;105(4):1590-6
6285911
J Biol Chem. 1993 Jul 15;268(20):15118-26
8392065
Exp Physiol. 2009 Jan;94(1):138-51
18931045
Am J Physiol Endocrinol Metab. 2006 Feb;290(2):E299-307
16219669
Nat Rev Cancer. 2007 Sep;7(9):684-700
17721433
Oncology. 2006;70(6):447-57
17237620
Endocrinology. 2000 Aug;141(8):2829-36
10919269
Nat Genet. 1997 Aug;16(4):391-6
9241280
Life Sci. 2009 Jul 17;85(3-4):146-52
19490920
Int J Obes (Lond). 2008 Aug;32(8):1305-11
18427562
Carcinogenesis. 2001 Sep;22(9):1429-35
11532865
J Nutr. 1996 Apr;126(4 Suppl):1159S-64S
8642450
Int J Cancer. 2009 Sep 15;125(6):1328-33
19437538
Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9315-9
1656468
Cancer. 2006 May 15;106(10):2136-42
16598750